Home
 /
Papers
 /
Synthetic Biology
 /
Bridge recombinase enables versatile rewriting of bacterial genomes
Preprint
Open access
V1
Top 1% · Validated by QED

Bridge recombinase enables versatile rewriting of bacterial genomes

Jaymin R. Patel, Sophia E. Swartz, Agnès Oromí-Bosch +19 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.04.29.721476
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Synthetic Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By establishing bridge recombinase as a programmable, cross-phylum genome editing platform capable of megabase-scale rearrangements and directional horizontal gene transfer, this work transforms microbiome engineering from organism-specific tinkering into controlled, ecosystem-level rewriting.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

When bridge recombinase is directed by two bridge RNAs that each specify one of two recombination junctions, it can programmably swap two distinct, large DNA segments in a single step, a genuine genomic "search-and-replace" we call TRADE editing. To achieve high-fidelity TRADE editing, we engineered orthogonal bRNAs that act like color-coded wires, so the left and right junctions each connect only to their matching ends rather than cross-wiring. This effectively makes it possible to pick up any piece of DNA and move it to any location in any other DNA molecule. Harnessing this, we achieved Programmable Horizontal Gene Transfer: relocation of large, defined regions of chromosomal DNA between diverse bacteria to confer new functional traits on demand.

”
Brady F. Cress

QED claims analysis

Summary

Bridge recombinase enables programmable, versatile genome editing across diverse bacterial phyla and intact microbial communities, performing insertions up to 142 kb, inversions up to 2.3 Mb, and pathway-scale excisions with high efficiency in single steps, while optimized dual-bRNA systems achieve search-and-replace editing and programmable horizontal gene transfer of functional biosynthetic pathways between phyla without reliance on homologous recombination or host-specific factors.

See full analysis
Main Claim 1 –

Bridge recombinase inserts DNA payloads up to 142 kb efficiently

Main Claim 2 –

Bridge recombinase enables programmable genome excisions and inversions

Supporting evidence

  • Bridge recombinase excises pathways up to 50 kb size-independently
  • Bridge recombinase inverts chromosomal segments up to 2.3 Mb
Main Claim 3 –

Bridge recombinase edits genomes across diverse bacterial phyla

Main Claim 4 –

Bridge recombinase enables direct genome editing in microbiome communities

Abstract

Bacteria drive crucial processes across ecosystems and profoundly impact human health, yet tools to rewrite microbiomes remain limited. Here, we show that bridge recombinase enables versatile and programmable genome editing across the bacterial tree of life. In Escherichia coli, we achieved 142 kb insertions at >90% efficiency, megabase-scale inversions (2.3 Mb), and pathway-scale 50 kb excisions. With a single ortholog and bridge RNA (bRNA), we edited bacterial isolates spanning five phyla and performed metagenomic editing in human gut microbiomes. We overcame cross-reactivity between co-expressed bRNAs to establish single-step search-and-replace editing, and demonstrated capture and interphylum transfer of functional chromosomal pathways, enabling programmable horizontal gene transfer. These advances establish bridge recombinase as a foundation for orchestrating controlled gene flow in complex microbial ecosystems.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?